title: Bedaquiline.
authors.affiliation: Centre for Human Drug Research, Leiden, the Netherlands.
authors.forename: Sebastiaan C
authors.identifier: http://orcid.org/0000-0003-3369-6107
authors.initials: SC
authors.lastname: Goulooze
authors.affiliation: Centre for Human Drug Research, Leiden, the Netherlands.|Leiden University Medical Center, Leiden, the Netherlands.
authors.forename: Adam F
authors.identifier: http://orcid.org/0000-0001-7452-6222
authors.initials: AF
authors.lastname: Cohen
authors.affiliation: Centre for Human Drug Research, Leiden, the Netherlands.|Leiden University Medical Center, Leiden, the Netherlands.
authors.forename: Robert
authors.initials: R
authors.lastname: Rissmann
mesh_terms: D025181:ATP Synthetase Complexes / Q000037:antagonists & inhibitors*; D000995:Antitubercular Agents / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D017322:Clinical Trials, Phase II as Topic; D064687:Diarylquinolines / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D024901:Drug Resistance, Multiple, Bacterial; D006801:Humans; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000201:enzymology; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy* / Q000382:microbiology; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000382:microbiology
chemical_list: D000995:Antitubercular Agents; D064687:Diarylquinolines; C493870:bedaquiline; D025181:ATP Synthetase Complexes
keywords: bedaquiline; multidrug-resistant tuberculosis; therapeutic use